Additionally, elevated levels of chronic inflammation markers, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), along with reduced secretion of muscle-derived factors, may further contribute to hepatic steatosis and liver inflammation. This evidence concerns the gene IL6 and fatty liver disease.